Key result
Catheter ablation linked to ~5-point higher 6-month AFEQT symptom scores in low-risk AF.
Why the study?
Impacts of a single radiofrequency ablation on quality of life were not well investigated in atrial fibrillation patients with low stroke risk.
Does radiofrequency ablation improve quality of life in atrial fibrillation patients with low stroke risk compared to non-RFA treatment?
Cohort (n=222)
Does radiofrequency ablation improve quality of life in atrial fibrillation patients with low stroke risk compared to non-RFA treatment?
Answers are grounded in this paper and cite their sources.
In atrial fibrillation patients with low stroke risk, radiofrequency ablation provides small-to-moderate improvements in symptoms and treatment satisfaction at 6 months compared to non-RFA treatment, though overall QoL improvements are similar.
Background Impacts of a single radiofrequency ablation ( RFA ) on quality of life (QoL) were not well investigated in atrial fibrillation ( AF ) patients with low stroke risk. Methods and Results Nine hundred AF patients with low CHADS 2 score (ie, CHADS 2 ≤1) who completed both a baseline and 6‐month Atrial Fibrillation Effect on QualiTy‐of‐life ( AFEQT ) questionnaire were selected from The Chinese Atrial Fibrillation Registry between 2011 and 2013. A final cohort of 222 patients was constructed after a propensity score matching with 74 in the RFA group and 148 in the non‐ RFA group. Domains of AFEQT were balanced at baseline between the 2 groups. No statistically significant differences were noted in QoL (all P >0.05) when AFEQT at 6 months was compared between groups, except for the symptoms domain (83.07±12.37 units in the RFA group vs. 77.68±17.14 units in the non‐ RFA group; P =0.008) and treatment satisfaction domain (76.34±14.92 units in the RFA group vs. 70.38±16.81 units in the non‐ RFA group; P =0.01). Within‐group changes in all domains and the global score of the questionnaire were moderate to large, whereas between‐group comparisons in baseline to 6‐month changes and QoL at 6 months were small to moderate according to Cohen effect sizes. Conclusions QoL was balanced at baseline and improved at 6 months in both groups from this observational propensity‐matched cohort based on the AFEQT questionnaire. However, RFA treatment was only associated with small‐to‐moderate superiorities over non‐ RFA treatment. The role of RFA in QoL improvement among AF patients with low stroke risk requires further research.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2015) conducted a cohort in Atrial fibrillation with low stroke risk (n=222). Radiofrequency ablation (RFA) vs. Non-RFA treatment was evaluated on Quality of life at 6 months (AFEQT symptoms domain score) (p=0.008). Among atrial fibrillation patients with low stroke risk, radiofrequency ablation was associated with higher AFEQT symptom scores at 6 months compared to non-ablation (83.07 vs 77.68; P=0.008).
Synapse has enriched 10 related papers. Consider them for comparative context: